Target intelligence / Profile preview

Ubiquitin C (UBC)

Target
UBC
Molecular classification
Other (precursor protein/gene for ubiquitin), Protein modifier (ubiquitin family)
01

Overview

Ubiquitin C (*UBC*) is a gene that encodes a polyubiquitin precursor protein comprising tandem repeats of the highly conserved ubiquitin monomer. Upon cellular stress such as heat shock, oxidative stress, and proteotoxic insults, UBC transcription is upregulated to maintain ubiquitin homeostasis and facilitate the removal of damaged or misfolded proteins. Polyubiquitin chains formed from ubiquitin C serve non-redundant cellular functions depending on linkage type, including targeting proteins for proteasomal degradation, regulating DNA repair, controlling cell cycle progression, mediating kinase signaling, and organizing autophagy or innate immune responses. Loss of UBC function results in developmental failure, demonstrating its essential role in cellular viability and stress adaptation. While ubiquitin and its conjugation pathway are central to many diseases and therapeutic strategies, UBC itself is not typically targeted by drugs, with therapies focusing on downstream proteasome activities or ubiquitin pathway enzymes

Other names
Polyubiquitin-CUBCUbiquitin
02

Mechanism of action

Drugs such as proteasome inhibitors block the degradation of ubiquitinated proteins. Modulators of protein homeostasis impact the ubiquitination pathway indirectly.

03

Biological functions

Protein degradation (via the ubiquitin-proteasome pathway)DNA repairCell cycle regulationKinase modificationEndocytosisApoptosisSignal transductionCellular stress responseInnate immunityRegulation of autophagy
04

Disease associations

CancerNeurodegenerative diseasesDevelopmental disorders (e.g., embryonic lethality upon gene loss)Protein aggregation disordersInfection (by involvement in cellular stress responses)Other (general cellular pathologies linked to protein homeostasis)
05

Safety considerations

Therapeutic manipulation of the ubiquitin pathway can lead to toxicity due to broad cellular involvement.Gene loss leads to embryonic lethality and impaired stress tolerance.Off-target effects due to the central role of ubiquitin in multiple cellular processes
06

Interacting drugs

No approved drugs directly target UBC. Multiple drugs (e.g., proteasome inhibitors like bortezomib) act upon the downstream ubiquitin-proteasome system, not on the UBC gene or its precursor protein directly
07

Biomarkers

Changes in ubiquitin conjugate levels (total ubiquitin, polyubiquitin chains) can serve as biomarkers in diseases such as cancer and neurodegeneration, but UBC gene expression itself is less commonly used as a clinical biomarker

Beyond the preview

Go deeper on Ubiquitin C (UBC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin C (UBC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call